The current number of shares outstanding for BioGene is 23 million and its current PE ratio is 49. Assuming a yearly growth in earnings of 50 per- cent for the next four years and a decline in the PE ratio to 25, this implies a valuation of $962 million in 2022. Assume InterWebs earnings (after-tax profits) in 2022 are $6.3 million as stated in their business plan. Assigning a PE ratio of 50 of InterWeb in 2022, what will be their valuation?